跳至主要内容
临床试验/NCT02504450
NCT02504450已完成不适用

Outcomes of Antipsychotic Medication Use in the Emergency Department: A Retrospective Comparison Study

Wake Forest University Health Sciences0 个研究点目标入组 93 人开始时间: 2015年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
93
主要终点
Length of stay in the emergency department

研究概览

简要总结

To review records of patients treated with antipsychotics (including Adasuve, Geodon, Haldol) in order to evaluate outcomes.

详细描述

A retrospective chart review will be performed for all patients presenting to the ED with agitation and subsequently given antipsychotic therapy for treatment. Identification of patients will be through chart review of patients presenting with agitation. Data to be recorded include patient age, gender, medical history, time of presentation, time of treatment, co morbidities, use of restraint, time to disposition and patient outcome. Inclusion criteria include all patients over age 18 presenting to the ED with agitation and treated with antipsychotics. No patients will be knowingly excluded from analysis. We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients given antipsychotic therapy for acute agitation

排除标准

  • 未提供

结局指标

主要结局

Length of stay in the emergency department

时间窗: Participants will be followed for the duration of emergency department stay, an expected average of 12 hours.

We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.

次要结局

  • Disposition(Participants will be followed for the duration of emergency department stay, an expected average of 12 hours.)

研究者

申办方类型
Other
责任方
Sponsor

相似试验